Efforts to assess the potency of benzyl chloride as a carcinogen and skin tumor initiator provided predominantly negative results. Coombs (1982a)
applied 1.0 mg benzyl chloride in toluene to the backs of 40 T.O. (Swiss- Webster derived Theiler's Original) mice, followed by twice weekly
treatments of croton oil in toluene for 10 months. While 8/19 positive controls treated with 0.4 mg benzo[a]pyrene developed skin tumors, none (0/37)
of the benzyl chloride-treated mice did. In a second initiation-promotion test, Coombs (1982b) topically applied 10, 100, or 1000 ug benzyl chloride
in acetone, followed by twice weekly applications of the promotor 12-O-tetra-'3-decanoyl- phorbol-'3-acetate. At the end of 11 weeks, all of the
positive controls treated with (7,12-dimethylbenz[a]anthracene) had skin tumors, whereas at 6 months (approximately 12 weeks later), only 20% of the
mice treated with benzyl chloride showed similar changes. Ashby et al. (1982) topically treated groups of 20 Swiss mice with 100 ug benzyl chloride in
toluene twice weekly. After 7.5 months, none of the treated mice had skin tumors compared with 18/20 of the positive controls treated with
benzo[a]pyrene.
Druckrey et al. (1970) administered benzyl chloride in peanut oil via weekly subcutaneous injection to BD-strain rats for 51 weeks. Local sarcomas
were produced in 3/14 rats given 40 mg/kg/week and in 6/8 rats given 80 mg/kg/week. The average induction time was 500 days and metastases to the lung
occurred in the high-dose group only.
Groups of 20 strain A/H mice were injected intraperitoneally over a 24- week period with benzyl chloride in tricaprylin (total doses of 4.7, 11.8, or
15.8 mmol/kg). No differences in pulmonary adenoma formation between treated and vehicle control mice were observed (Poirier et al., 1975).
|